Filing Details
- Accession Number:
- 0001437749-19-018984
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2019-09-24 17:34:46
- Reporting Period:
- 2018-05-16
- Accepted Time:
- 2019-09-24 17:34:46
- Original Submission Date:
- 2018-06-14
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1029125 | Sun Biopharma Inc. | SNBP | Pharmaceutical Preparations (2834) | 870543922 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1652797 | W. Paul Schaffer | 712 Vista Blvd #305 Waconia MN 55387 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-05-16 | 2,000 | $0.00 | 94,420 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2018-05-16 | 11,756 | $0.00 | 30,665 | No | 4 | C | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | C | Direct |
Footnotes
- Reflects purchase of 5,000 units from the issuer at a price equal to $5.00 per unit. Each unit consisted of one share of common stock and a warrant to purchase an additional share of common stock.
- Pursuant to the "alternate conversion" under the Convertible Promissory Note, approximately $52,902 of outstanding principal and accrued but unpaid interest converted into 11,756 units at a price equal to $4.50 per unit. Each unit consisted of one share of common stock and a warrant to purchase an additional share of common stock.
- Amended solely to correct balances to reflect reverse stock split effective November 7, 2017.